Ocugen to Spotlight Groundbreaking Gene Therapy Research at ARVO 2024
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) is poised to make a significant impact at the Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting in Seattle, WA, …
Ocugen to Spotlight Groundbreaking Gene Therapy Research at ARVO 2024 Read More